149 related articles for article (PubMed ID: 38182822)
21. IRF7-dependent type I interferon production induces lethal immune-mediated disease in STAT1 knockout mice infected with lymphocytic choriomeningitis virus.
Li W; Hofer MJ; Jung SR; Lim SL; Campbell IL
J Virol; 2014 Jul; 88(13):7578-88. PubMed ID: 24760883
[TBL] [Abstract][Full Text] [Related]
22. Aplastic anemia rescued by exhaustion of cytokine-secreting CD8+ T cells in persistent infection with lymphocytic choriomeningitis virus.
Binder D; van den Broek MF; Kägi D; Bluethmann H; Fehr J; Hengartner H; Zinkernagel RM
J Exp Med; 1998 Jun; 187(11):1903-20. PubMed ID: 9607930
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-27R Signaling Mediates Early Viral Containment and Impacts Innate and Adaptive Immunity after Chronic Lymphocytic Choriomeningitis Virus Infection.
Harker JA; Wong KA; Dallari S; Bao P; Dolgoter A; Jo Y; Wehrens EJ; Macal M; Zuniga EI
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593047
[TBL] [Abstract][Full Text] [Related]
24. Immunosuppression by lymphocytic choriomeningitis virus infection: competent effector T and B cells but impaired antigen presentation.
Althage A; Odermatt B; Moskophidis D; Kündig T; Hoffman-Rohrer U; Hengartner H; Zinkernagel RM
Eur J Immunol; 1992 Jul; 22(7):1803-12. PubMed ID: 1623925
[TBL] [Abstract][Full Text] [Related]
25. Replication-incompetent rabies virus vector harboring glycoprotein gene of lymphocytic choriomeningitis virus (LCMV) protects mice from LCMV challenge.
Takayama-Ito M; Lim CK; Yamaguchi Y; Posadas-Herrera G; Kato H; Iizuka I; Islam MT; Morimoto K; Saijo M
PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006398. PubMed ID: 29659579
[TBL] [Abstract][Full Text] [Related]
26. PD-L1 Checkpoint Inhibition Narrows the Antigen-Specific T Cell Receptor Repertoire in Chronic Lymphocytic Choriomeningitis Virus Infection.
Klein S; Ghersi D; Manns MP; Prinz I; Cornberg M; Kraft ARM
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641478
[TBL] [Abstract][Full Text] [Related]
27. Microcephaly Caused by Lymphocytic Choriomeningitis Virus.
Delaine M; Weingertner AS; Nougairede A; Lepiller Q; Fafi-Kremer S; Favre R; Charrel R
Emerg Infect Dis; 2017 Sep; 23(9):1548-1550. PubMed ID: 28820372
[TBL] [Abstract][Full Text] [Related]
28. Lymphocytic choriomeningitis virus: An under-recognized congenital teratogen.
Ferenc T; Vujica M; Mrzljak A; Vilibic-Cavlek T
World J Clin Cases; 2022 Sep; 10(25):8922-8931. PubMed ID: 36157656
[TBL] [Abstract][Full Text] [Related]
29. Lymphocytic Choriomeningitis-Emerging Trends of a Neglected Virus: A Narrative Review.
Vilibic-Cavlek T; Savic V; Ferenc T; Mrzljak A; Barbic L; Bogdanic M; Stevanovic V; Tabain I; Ferencak I; Zidovec-Lepej S
Trop Med Infect Dis; 2021 May; 6(2):. PubMed ID: 34070581
[TBL] [Abstract][Full Text] [Related]
30. Lymphocytic Choriomeningitis Virus Differentially Affects the Virus-Induced Type I Interferon Response and Mitochondrial Apoptosis Mediated by RIG-I/MAVS.
Pythoud C; Rothenberger S; Martínez-Sobrido L; de la Torre JC; Kunz S
J Virol; 2015 Jun; 89(12):6240-50. PubMed ID: 25833049
[TBL] [Abstract][Full Text] [Related]
31. An acquired immune suppression in mice caused by infection with lymphocytic choriomeningitis virus.
Roost H; Charan S; Gobet R; Rüedi E; Hengartner H; Althage A; Zinkernagel RM
Eur J Immunol; 1988 Apr; 18(4):511-8. PubMed ID: 2452742
[TBL] [Abstract][Full Text] [Related]
32. PC61 (anti-CD25) treatment inhibits influenza A virus-expanded regulatory T cells and severe lung pathology during a subsequent heterologous lymphocytic choriomeningitis virus infection.
Kraft AR; Wlodarczyk MF; Kenney LL; Selin LK
J Virol; 2013 Dec; 87(23):12636-47. PubMed ID: 24049180
[TBL] [Abstract][Full Text] [Related]
33. Heterologous Immunity and Persistent Murine Cytomegalovirus Infection.
Che JW; Daniels KA; Selin LK; Welsh RM
J Virol; 2017 Jan; 91(2):. PubMed ID: 27807227
[TBL] [Abstract][Full Text] [Related]
34. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence.
Ahmed R; Salmi A; Butler LD; Chiller JM; Oldstone MB
J Exp Med; 1984 Aug; 160(2):521-40. PubMed ID: 6332167
[TBL] [Abstract][Full Text] [Related]
35. Immunopathological basis of lymphocytic choriomeningitis virus-induced chorioretinitis and keratitis.
Zinkernagel MS; Bolinger B; Krebs P; Onder L; Miller S; Ludewig B
J Virol; 2009 Jan; 83(1):159-66. PubMed ID: 18945766
[TBL] [Abstract][Full Text] [Related]
36. Virus-induced transient bone marrow aplasia: major role of interferon-alpha/beta during acute infection with the noncytopathic lymphocytic choriomeningitis virus.
Binder D; Fehr J; Hengartner H; Zinkernagel RM
J Exp Med; 1997 Feb; 185(3):517-30. PubMed ID: 9053452
[TBL] [Abstract][Full Text] [Related]
37. Childhood blindness and visual loss: an assessment at two institutions including a "new" cause.
Mets MB
Trans Am Ophthalmol Soc; 1999; 97():653-96. PubMed ID: 10703143
[TBL] [Abstract][Full Text] [Related]
38. Altered central nervous system gene expression caused by congenitally acquired persistent infection with lymphocytic choriomeningitis virus.
Kunz S; Rojek JM; Roberts AJ; McGavern DB; Oldstone MB; de la Torre JC
J Virol; 2006 Sep; 80(18):9082-92. PubMed ID: 16940520
[TBL] [Abstract][Full Text] [Related]
39. Persistent dentate granule cell hyperexcitability after neonatal infection with lymphocytic choriomeningitis virus.
Pearce BD; Steffensen SC; Paoletti AD; Henriksen SJ; Buchmeier MJ
J Neurosci; 1996 Jan; 16(1):220-8. PubMed ID: 8613788
[TBL] [Abstract][Full Text] [Related]
40. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. VI. Migration and activity in vivo in acute and persistent infection.
Byrne JA; Oldstone MB
J Immunol; 1986 Jan; 136(2):698-704. PubMed ID: 2416821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]